MBX - MBX Biosciences Inc Forward P/S Multiple

MBX Biosciences Inc (MBX) is actively developing its portfolio of endocrine agents to meet global medical demand. Its U.S.-based technological foundation and successful tests ensure process stability. High R&D expenditures and stringent FDA oversight create significant barriers to entry for competitors. The company's forward P/S ratio demonstrates the correlation between share prices and revenue expectations, with the metric currently holding around .

MBX MBX Biosciences: Market Cap to Expected Sales Ratio in the range 07/04/2022 - 11/14/2026

Summary analytical data breakdowns for MBX Corp (MBX)

- market price and analyst price targets:

Price Chart MBX Biosciences|MBX - Price Target Chart

- market capitalization statistics:

Market Capitalization MBX Corp|MBX - Company Buyout Price

- issuer book value statistics:

Net Assets per Single Share MBX Biosciences|MBX - Book Valuation of Business|Market Value to Book Value Ratio mbxbio.com|MBX - Cumulative Company Assets

- company liabilities and liquidity data:

- business earnings and investment ratios data:

MBX - Company Net Income|Projected Future Earnings MBX Biosciences Inc|MBX - Business Payback Period|Future Price to Earnings MBX Bio|MBX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MBX Corp|MBX - Operating income before deduction of amortization|Net earnings per share (EPS TTM) MBX Biosciences|MBX - Net earnings per share for the last 12 months|Quarterly EPS earnings growth mbxbio.com|MBX - Expected net earnings per share growth this year|Earnings growth forecast for next year MBX Biosciences Inc

- sales volume and revenue indicators:

MBX - Company Total Revenue|Company Projected Revenue MBX Biosciences|MBX - Market Cap to Revenue Ratio|Forward P/S Multiple MBX Corp

Summary company analytics:MBX Biosciences (MBX)

This metric compares the current market value of MBX Biosciences Inc (MBX) with expected sales volume, providing a real-time assessment of fluctuations in market expectations regarding future cash flows. The price-to-sales (P/S) forward ratio trend allows for the identification of periods of irrational discount or asset overvaluation, which is critical for evaluating promising endocrinology developments during the clinical trial stage.

Competitor analysis for MBX Biosciences Inc

Price-to-Projected Revenue Ratio Ascendis Pharma ASND|Madrigal Pharmaceuticals Inc - Price-to-Projected Revenue Ratio|Corcept - Forward P/S Multiple|Market Cap to Expected Sales Ratio Rhythm Corp RYTM|Akero Therapeutics (AKRO) - Price-to-Projected Revenue Ratio|MTSR - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio MoonLake|Forward Price-to-Revenue Multiple Crinetics Pharmaceuticals, Inc. (CRNX)|Price-to-Projected Revenue Ratio NewAmsterdam Pharma N.V. (NAMS)|Forward Price-to-Revenue Multiple Soleno Therapeutics Corp SLNO|Forward P/S Multiple FOLD (Amicus Therapeutics)|89bio.com - Price-to-Projected Revenue Ratio|AGIO: Forward Price-to-Revenue Multiple|GPCR (Structure Therapeutics Inc) - Market Cap to Projected Revenue|MDXG (MiMedx Group) - Forward Price-to-Revenue Multiple|Rezolute Bio - Forward Price to Sales|LXRX (Lexicon Pharmaceuticals) - Forward P/S Multiple|Price-to-Projected Revenue Ratio ALT|Forward P/S Multiple AARD|Market Cap to Expected Sales Ratio Sagimet Biosciences, Inc.|Price-to-Projected Revenue Ratio BioAge Labs Inc. BIOA|Biomea Fusion Corp (BMEA) - Market Cap to Future Revenue Ratio|QNCX - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio fractyl.com GUTS|VTVT: Forward P/S Multiple|Forward Price-to-Revenue Multiple Agape ATP|PLUR (Pluristem Therapeutics) - Forward P/S Multiple|Synlogic Corp (SYBX) - Market Cap to Expected Sales Ratio|Forward P/S Multiple LPCN|MTNB - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Spruce Biosciences, Inc. SPRB|GLTO: Market Cap to Projected Revenue|Carmell Corp - Forward P/S Multiple|Lumos Therapeutics (LUMO) - Forward Price-to-Revenue Multiple|ONVO: Forward P/S Multiple|Market Cap to Future Revenue Ratio radiuspharm.com (RDUS)